Cogent Biosciences logo

Cogent Biosciences Share Price Today

(NASDAQ: COGT)

Cogent Biosciences share price is $9.25 & ₹805.63 as on 5 Feb 2025, 2.30 'hrs' IST

$9.25

0.26

(2.89%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Cogent Biosciences share price in Dollar and Rupees. Guide to invest in Cogent Biosciences stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Cogent Biosciences, along with analyst recommendations, forecasts, and comprehensive financials.

Cogent Biosciences share price movements

  • Today's Low: $8.94
    Today's High: $9.30

    Day's Volatility :3.82%

  • 52 Weeks Low: $4.62
    52 Weeks High: $12.61

    52 Weeks Volatility :63.36%

Cogent Biosciences (COGT) Returns

PeriodCogent Biosciences IncSector (Health Care)Index (Russel 2000)
3 Months
-14.22%
0.5%
0.0%
6 Months
4.17%
-2.3%
0.0%
1 Year
49.09%
3.8%
0.0%
3 Years
27.52%
11.4%
-11.7%

Cogent Biosciences (COGT) Key Statistics

in dollars & INR

Previous Close
$8.99
Open
$8.96
Today's High
$9.295
Today's Low
$8.94
Market Capitalization
$1.0B
Today's Volume
$1.1M
52 Week High
$12.61
52 Week Low
$4.62
Revenue TTM
$0.0
EBITDA
$-258.0M
Earnings Per Share (EPS)
$-2.48
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-78.47%

How to invest in Cogent Biosciences Stock (COGT) from India?

It is very easy for Indian residents to invest directly in Cogent Biosciences from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cogent Biosciences stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cogent Biosciences or COGT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cogent Biosciences or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cogent Biosciences shares which would translate to 0.094 fractional shares of Cogent Biosciences as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Cogent Biosciences, in just a few clicks!

Returns in Cogent Biosciences (COGT) for Indian investors in Rupees

The Cogent Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Cogent Biosciences investment value today

Current value as on today

₹1,58,264

Returns

₹58,264

(+58.26%)

Returns from Cogent Biosciences Stock

₹53,400 (+53.4%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Cogent Biosciences (COGT)

26%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Cogent Biosciences Stock from India on INDmoney has increased by 26% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Cogent Biosciences

  • Point72 Asset Management, L.P.

    9.48%

  • Kynam Capital Management, LP

    8.36%

  • FMR Inc

    7.53%

  • BlackRock Inc

    7.23%

  • COMMODORE CAPITAL LP

    6.83%

  • TCG Crossover Management, LLC

    6.30%

Analyst Recommendation on Cogent Biosciences

Buy

    82%Buy

    17%Hold

    0%Sell

Based on 17 Wall street analysts offering stock ratings for Cogent Biosciences(by analysts ranked 0 to 5 stars)

Based on 17 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
14
14
14
Hold
3
3
2
Sell
0
0
0

Analyst Forecast on Cogent Biosciences Stock (COGT)

What analysts predicted

Upside of 78.38%

Target:

$16.50

Current:

$9.25

Insights on Cogent Biosciences Stock (Ticker Symbol: COGT)

  • Price Movement

    In the last 1 month, COGT stock has moved up by 14.1%
  • COGT vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 56.4%

Cogent Biosciences Technicals Summary

Sell

Neutral

Buy

Cogent Biosciences is currently in a neutral trading position according to technical analysis indicators.

Cogent Biosciences (COGT) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Cogent Biosciences Inc logo
11.54%
4.17%
49.09%
27.52%
1055.82%
Biontech Se logo
-0.32%
51.19%
24.81%
-30.66%
288.02%
Regeneron Pharmaceuticals, Inc. logo
-6.9%
-37.55%
-28.89%
7.15%
74.63%
Vertex Pharmaceuticals Incorporated logo
16.87%
0.96%
13.03%
93.36%
95.94%
Alnylam Pharmaceuticals, Inc. logo
17.76%
5.53%
59.46%
84.7%
118.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Cogent Biosciences Inc logo
NA
NA
NA
-2.4
-0.78
-0.44
NA
1.85
Biontech Se logo
160.8
NA
0.04
-3.32
-0.02
-0.01
NA
79.73
Regeneron Pharmaceuticals, Inc. logo
16.64
16.64
1.08
44.92
0.17
0.07
NA
272.04
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.21
0.49
-0.03
0.12
NA
60.65
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
-0.18
-15.01
-0.03
NA
0.25
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Cogent Biosciences Inc logo
Buy
$1.0B
1055.82%
NA
0.0%
Biontech Se logo
Buy
$29.7B
288.02%
160.8
-15.36%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.0B
74.63%
16.64
33.61%
Vertex Pharmaceuticals Incorporated logo
Buy
$118.9B
95.94%
32.84
-4.51%
Alnylam Pharmaceuticals, Inc. logo
Buy
$35.0B
118.8%
NA
-15.86%

About Cogent Biosciences

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Organization
Cogent Biosciences
Employees
164
CEO
Mr. Andrew R. Robbins M.B.A.
Industry
Health Technology

Management People of Cogent Biosciences

NameTitle
Mr. Andrew R. Robbins M.B.A.
President, CEO & Director
Dr. John Edward Robinson Ph.D.
Chief Scientific Officer
Dr. Jessica Sachs M.D.
Chief Medical Officer
Mr. John L. Green C.A., CPA
CFO & Principal Accounting Officer
Mr. Brad Barnett
Chief Technology Officer
Ms. Christi Waarich
Senior Director of Investor Relations
Mr. Evan D. Kearns J.D.
Chief Legal Officer & Corporate Secretary
Ms. Erin Schellhammer
Chief People Officer
Mr. Dana R. Martin Pharm.D.
Senior VP of Medical Affairs & Chief Patient Officer
Brad Fell
Senior Vice President of Chemistry

Important FAQs about investing in COGT Stock from India :

What is Cogent Biosciences share price today?

Cogent Biosciences share price today stands at $9.25, Open: $8.96 ; Previous Close: $8.99 ; High: $9.30 ; Low: $8.94 ; 52 Week High: $12.61 ; 52 Week Low: $4.62.

The stock opens at $8.96, after a previous close of $8.99. The stock reached a daily high of $9.30 and a low of $8.94, with a 52-week high of $12.61 and a 52-week low of $4.62.

Can Indians buy Cogent Biosciences shares?

Yes, Indians can invest in the Cogent Biosciences (COGT) from India.

With INDmoney, you can buy Cogent Biosciences at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Cogent Biosciences at zero transaction cost.

How can I buy Cogent Biosciences shares from India?

It is very easy to buy Cogent Biosciences from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cogent Biosciences (COGT) be purchased?

Yes, you can buy fractional shares of Cogent Biosciences with INDmoney app.

What are the documents required to start investing in Cogent Biosciences stocks?

To start investing in Cogent Biosciences, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Cogent Biosciences Stock (COGT)?

Today’s highest price of Cogent Biosciences (COGT) is $9.30.

Today’s lowest price of Cogent Biosciences (COGT) is $8.94.

What is today's market capitalisation of Cogent Biosciences?

Today's market capitalisation of Cogent Biosciences COGT is 1.0B

What is the 52 Week High and Low Range of Cogent Biosciences Stock (COGT)?

  • 52 Week High

    $12.61

  • 52 Week Low

    $4.62

What are the historical returns of Cogent Biosciences (COGT)?

  • 1 Month Returns

    11.54%

  • 3 Months Returns

    4.17%

  • 1 Year Returns

    49.09%

  • 5 Years Returns

    1055.82%

Who is the Chief Executive Officer (CEO) of Cogent Biosciences ?

Mr. Andrew R. Robbins M.B.A. is the current Chief Executive Officer (CEO) of Cogent Biosciences.